up and up mucus relief
NDC 11673-421, guaifenesin, tablet, multilayer, extended release, from Target Corporation.
- Product NDC
- 11673-421
- Status
- Listed
- Labeler
- Target Corporation
- Dosage form
- TABLET, MULTILAYER, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA078912
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11673-421 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11673-421-01 | 11673042101 | 1 BLISTER PACK in 1 CARTON (11673-421-01) / 20 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11673-421 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11673-421 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11673-421. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.